ArticleBMC cancer2007

Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer.

Bhumsuk Keam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.